Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Chimeric Therapeutics Ltd. ( (AU:CHM) ) just unveiled an update.
Chimeric Therapeutics Limited has applied for quotation on the ASX of 466,666,665 new fully paid ordinary shares, to be issued on 31 December 2025 under its existing capital management program. The substantial increase in quoted securities signals a significant capital move that may affect the company’s ownership structure and liquidity, with implications for existing shareholders as the enlarged share base begins trading on the market.
The most recent analyst rating on (AU:CHM) stock is a Hold with a A$0.01 price target. To see the full list of analyst forecasts on Chimeric Therapeutics Ltd. stock, see the AU:CHM Stock Forecast page.
More about Chimeric Therapeutics Ltd.
Technical Sentiment Signal: Sell
Current Market Cap: A$10.93M
For a thorough assessment of CHM stock, go to TipRanks’ Stock Analysis page.